Literature DB >> 23332928

Intestinal γδ T-cell lymphomas are most frequently of type II enteropathy-associated T-cell type.

Amanda L Wilson1, Steven H Swerdlow, Grzegorz K Przybylski, Urvashi Surti, John K Choi, Elias Campo, Massimo M Trucco, S Branden Van Oss, Raymond E Felgar.   

Abstract

Enteropathy-associated T-cell lymphoma includes type I cases and distinctive type II cases that, according to 2008 and 2010 World Health Organization descriptions, are T-cell receptor β+. Although T-cell receptor γδ enteropathy-associated T-cell lymphomas are reported, it is unknown if they have distinctive features and if they should be categorized as enteropathy-associated T-cell lymphoma or as a mucocutaneous γδ T-cell lymphoma. To address these questions, the clinicopathologic, immunophenotypic, molecular, and cytogenetic features of 5 γδ-enteropathy-associated T-cell lymphomas were investigated. Only 1 patient had celiac disease and had type I enteropathy-associated T-cell lymphoma, and the others fulfilled the histopathologic criteria for type II enteropathy-associated T-cell lymphoma. All lacked cutaneous involvement. A celiac disease-associated HLA type was found in the patient with CD and one of four others. All were T-cell receptor γ+, T-cell receptor δ+, βF1-, CD3+, CD7+, CD5-, CD4-, and TIA-1+ with variable staining for CD2 (3/5), CD8 (2/5), Granzyme B (1/5), and CD56 (4/5). Fluorescence in situ hybridization demonstrated 9q34 gains in 4 cases, with 9q33-34 gains by single nucleotide polymorphism in 3 of these. Single nucleotide polymorphism analysis also demonstrated gains in 5q34-q35.1/5q35.1 (4/5), 8q24 (3/5), and in 32 other regions in 3 of 5 cases. Vδ1 rearrangements were identified in 4 of 4 cases with documented clonality showing the same clone in normal-appearing distant mucosa (3/3 tested cases). Thus, γδ-enteropathy-associated T-cell lymphomas share many features with other enteropathy-associated T-cell lymphoma and are mostly of type II. Their usual nonactivated cytotoxic phenotype and Vδ1 usage are features unlike many other mucocutaneous γδ T-cell lymphomas but shared with hepatosplenic T-cell lymphoma. These findings support the conclusion that a γδ T-cell origin at extracutaneous sites does not define a specific entity.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332928      PMCID: PMC3660470          DOI: 10.1016/j.humpath.2012.10.002

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  26 in total

1.  Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes.

Authors:  G K Przybylski; H Wu; W R Macon; J Finan; D G Leonard; R E Felgar; J A DiGiuseppe; P C Nowell; S H Swerdlow; M E Kadin; M A Wasik; K E Salhany
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

2.  Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study.

Authors:  Tawatchai Pongpruttipan; Sanya Sukpanichnant; Thamathorn Assanasen; Pongsak Wannakrairot; Paisarn Boonsakan; Wasana Kanoksil; Kanita Kayasut; Winyou Mitarnun; Archrob Khuhapinant; Udomsak Bunworasate; Teeraya Puavilai; Anan Bedavanija; Adriana Garcia-Herrera; Elias Campo; James R Cook; John Choi; Steven H Swerdlow
Journal:  Am J Surg Pathol       Date:  2012-04       Impact factor: 6.394

3.  Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation.

Authors:  Adriana Garcia-Herrera; Joo Y Song; Shih-Sung Chuang; Neus Villamor; Luis Colomo; Stefania Pittaluga; Tomas Alvaro; Maria Rozman; Jazmin de Anda Gonzalez; Ana Maria Arrunategui; Eva Fernandez; Elena Gonzalvo; Teresa Estrach; Dolors Colomer; Mark Raffeld; Philippe Gaulard; Elias Campo; Elaine S Jaffe; Antonio Martinez
Journal:  Am J Surg Pathol       Date:  2011-08       Impact factor: 6.394

4.  Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma.

Authors:  S-Y Tan; A-S Ooi; M-K Ang; M Koh; J-C Wong; K Dykema; J Ngeow; S Loong; K Gatter; L Tan; L-C Lim; K Furge; M Tao; S-T Lim; F Loong; P L Cheah; B-T Teh
Journal:  Leukemia       Date:  2011-01-14       Impact factor: 11.528

5.  Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.

Authors:  Jan Delabie; Harald Holte; Julie M Vose; Fred Ullrich; Elaine S Jaffe; Kerry J Savage; Joseph M Connors; Lisa Rimsza; Nancy L Harris; Konrad Müller-Hermelink; Thomas Rüdiger; Bertrand Coiffier; Randy D Gascoyne; Françoise Berger; Kensei Tobinai; Wing Y Au; Raymond Liang; Emili Montserrat; Ephraim P Hochberg; Stefano Pileri; Massimo Federico; Bharat Nathwani; James O Armitage; Dennis D Weisenburger
Journal:  Blood       Date:  2011-05-12       Impact factor: 22.113

6.  Enteropathy-associated T-cell lymphoma--a clinicopathologic and array comparative genomic hybridization study.

Authors:  Young Hyeh Ko; Sivasundaram Karnan; Kyeong Mee Kim; Cheol Keun Park; Eun Suk Kang; Young Ho Kim; Won Ki Kang; Seok Jin Kim; Won Seog Kim; Woo Yong Lee; Ho Kyung Chun; Masao Seto
Journal:  Hum Pathol       Date:  2010-04-18       Impact factor: 3.466

7.  Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent γδ T-cell receptor expression.

Authors:  John K C Chan; Alexander C L Chan; Wah Cheuk; Suk-King Wan; Wai-Ki Lee; Yun-Hoi Lui; Wai-Kong Chan
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

8.  A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.

Authors:  J Soulier; G Pierron; D Vecchione; R Garand; F Brizard; F Sigaux; M H Stern; A Aurias
Journal:  Genes Chromosomes Cancer       Date:  2001-07       Impact factor: 5.006

9.  Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.

Authors:  A Katoh; K Ohshima; M Kanda; S Haraoka; M Sugihara; J Suzumiya; C Kawasaki; K Shimazaki; S Ikeda; M Kikuchi
Journal:  Leuk Lymphoma       Date:  2000-09

10.  Pathological and immunohistological findings and genetic aberrations of intestinal enteropathy-associated T cell lymphoma in Japan.

Authors:  Morishige Takeshita; Shotaro Nakamura; Kanta Kikuma; Yoshifuku Nakayama; Satoshi Nimura; Takashi Yao; Shogo Urabe; Satoshi Ogawara; Hirotoshi Yonemasu; Yoshifumi Matsushita; Kennosuke Karube; Akinori Iwashita
Journal:  Histopathology       Date:  2011-02-16       Impact factor: 5.087

View more
  8 in total

Review 1.  Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders.

Authors:  Susan Swee-Shan Hue; Siok-Bian Ng; Shi Wang; Soo-Yong Tan
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

Review 2.  Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification.

Authors:  Parwiz J Siaghani; Joo Y Song
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 4.213

3.  Novel variant of EATL evolving from mucosal γδ-T-cells in a patient with type I RCD.

Authors:  R L J van Wanrooij; D de Jong; A W Langerak; B Ylstra; H F van Essen; D A M Heideman; H J Bontkes; C J J Mulder; G Bouma
Journal:  BMJ Open Gastroenterol       Date:  2015-06-09

4.  JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma.

Authors:  M-L Nairismägi; J Tan; J Q Lim; S Nagarajan; C C Y Ng; V Rajasegaran; D Huang; W K Lim; Y Laurensia; G C Wijaya; Z M Li; I Cutcutache; W L Pang; S Thangaraju; J Ha; L P Khoo; S T Chin; S Dey; G Poore; L H C Tan; H K M Koh; K Sabai; H-L Rao; K L Chuah; Y-H Ho; S-B Ng; S-S Chuang; F Zhang; Y-H Liu; T Pongpruttipan; Y H Ko; P-L Cheah; N Karim; W-J Chng; T Tang; M Tao; K Tay; M Farid; R Quek; S G Rozen; P Tan; B T Teh; S T Lim; S-Y Tan; C K Ong
Journal:  Leukemia       Date:  2016-02-08       Impact factor: 11.528

5.  γδ T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Discussion of Two Pediatric Cases and Its Distinction from Other Mature γδ T-Cell Malignancies.

Authors:  Eric X Wei; Vasiliki Leventaki; John K Choi; Susana C Raimondi; Elizabeth M Azzato; Sheila A Shurtleff; Menchu G Ong; Diana M Veillon; James D Cotelingam; Rodney E Shackelford
Journal:  Case Rep Hematol       Date:  2017-09-24

6.  SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma.

Authors:  Grit Mutzbauer; Katja Maurus; Clara Buszello; Jordan Pischimarov; Sabine Roth; Andreas Rosenwald; Andreas Chott; Eva Geissinger
Journal:  Mod Pathol       Date:  2017-10-20       Impact factor: 8.209

7.  Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature.

Authors:  Sónia Fonseca; Vanessa Pereira; Catarina Lau; Maria Dos Anjos Teixeira; Marika Bini-Antunes; Margarida Lima
Journal:  Cells       Date:  2020-03-16       Impact factor: 6.600

Review 8.  The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.

Authors:  Susann Schönefeldt; Tamara Wais; Marco Herling; Satu Mustjoki; Vasileios Bekiaris; Richard Moriggl; Heidi A Neubauer
Journal:  Cancers (Basel)       Date:  2021-12-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.